VAD044

VAD044 · Vaderis Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VAD044, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Assess Safety and Efficacy of VAD044 in HHT Patients [Phase 1, Phase 2]